MintNeuro designs and supplies ultra-efficient, purpose-built integrated circuits for neural implants. Their chips are small, low-power, and meet medical-grade reliability standards. The company partners with medical device firms and research institutions to integrate these components into implantable systems for sensing, stimulation, and wireless communication.
Enable minimally invasive neural implants for epilepsy patients; Support wireless intracranial neuromonitoring for drug-resistant epilepsy; Power stimulation systems for Parkinson’s disease; Facilitate brain-computer interfaces for research applications; Enable scalable neuromodulation for dementia treatment
Secured £1M investment in 2024; Won three UK Government ARIA Awards; Named ChipStart Company of the Year; Secured £1.4M collaborative grant for epilepsy research; Partnerships with Imperial College London and Innovate UK